デフォルト表紙
市場調査レポート
商品コード
1604759

自己創傷パッチ市場:タイプ別、創傷別、流通チャネル別、エンドユーザー別-2025-2030年の世界予測

Autologous Wound Patches Market by Type (Platelet Rich Fibrin, Platelet Rich Plasma), Wound (Acute Wounds, Chronic Wounds), Distribution Channel, End-User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 193 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
自己創傷パッチ市場:タイプ別、創傷別、流通チャネル別、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

自己創傷パッチ市場は、2023年に7,824万米ドルと評価され、2024年には8,840万米ドルに達すると予測され、CAGR 13.39%で成長し、2030年には1億8,858万米ドルになると予測されています。

自己創傷パッチは、ヘルスケア産業における重要な技術革新であり、患者自身の細胞を用いて創傷治癒を促進する治療用パッチを作成します。これらのパッチの必要性は、自己細胞であるため感染や拒絶反応のリスクを大幅に低減できる可能性に起因しており、より高い生体適合性が保証されています。これらのパッチは、慢性創傷管理、外科的創傷、潰瘍治療など幅広い用途があり、またその自然な適合性と組織再生における有効性から、糖尿病性創傷治癒への応用も期待されています。最終使用範囲は病院、外来患者センター、専門クリニックに及び、ヘルスケアの普及を後押ししています。

主な市場の統計
基準年[2023] 7,824万米ドル
推定年[2024] 8,840万米ドル
予測年[2030] 1億8,858万米ドル
CAGR(%) 13.39%

自己創傷パッチ市場は、慢性創傷の増加、高度創傷ケアに対する意識の高まり、創傷合併症を起こしやすい高齢者人口の増加などが主な要因となっています。さらに、組織工学と再生医療における技術進歩が市場拡大に重要な役割を果たしています。潜在的な治療機会は、治療計画を個別化しパッチの効果を改善するためのAIと機械学習の統合にあります。市場関係者への提言としては、製品の有効性を高めるための研究開発への投資、販売網を強化するためのヘルスケアプロバイダーとの戦略的パートナーシップの確立などが挙げられます。

逆に、特に新興国市場では、高コスト、複雑な規制状況、限られた認知度といった制約が市場成長の課題となっています。さらに、自己細胞の採取と培養における技術的課題は、複雑さと潜在的なコスト負担に拍車をかけ、アクセシビリティを制限しています。この分野の技術革新は、バイオファブリケーション技術の強化に根ざしており、個別化医療のアプローチは、個々の患者のニーズに合わせた治療によって市場に革命をもたらす可能性があります。市場の性質はダイナミックで競争的であり、技術の進歩と規制当局の承認がヘルスケア需要の増大と効果的に整合するにつれて、高い成長の可能性が見込まれます。拡張性とコスト削減に注力することで、市場への浸透と受容がさらに加速する可能性があります。

市場力学:急速に進化する自己創傷パッチ市場の主要市場インサイトを公開

自己創傷パッチ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 急性および慢性創傷の世界の増加
    • 交通事故や外傷性事故の増加
    • 自己創傷パッチに対する有利な償還政策
  • 市場抑制要因
    • 自己創傷パッチに関連する高コスト
  • 市場機会
    • 創傷治癒用スマートパッチのイントロダクション
    • 自己創傷パッチ開発のための継続的研究活動
  • 市場の課題
    • 創傷治療の代替品の入手可能性

ポーターのファイブフォース:自己創傷パッチ市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:自己創傷パッチ市場における外部からの影響の把握

外部マクロ環境要因は、自己創傷パッチ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析自己創傷パッチ市場における競合情勢の把握

自己創傷パッチ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス自己創傷パッチ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、自己創傷パッチ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨自己創傷パッチ市場における成功への道筋を描く

自己創傷パッチ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 急性および慢性創傷の罹患率が世界的に上昇
      • 増加する道路交通事故と悲惨な事故
      • 自己創傷パッチの有利な払い戻しポリシー
    • 抑制要因
      • 自己創傷パッチに関連する高コスト
    • 機会
      • 創傷治癒のためのスマートパッチのイントロダクション
      • 自己創傷パッチの開発に向けた継続的な調査活動
    • 課題
      • 創傷治療の代替手段の利用可能性
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 自己創傷パッチ市場:タイプ別

  • 多血小板フィブリン
  • 多血小板血漿

第7章 自己創傷パッチ市場傷別

  • 急性創傷
    • バーンズ
    • 外科的創傷および外傷
  • 慢性創傷
    • 糖尿病性足潰瘍
    • 褥瘡
    • 静脈性下肢潰瘍

第8章 自己創傷パッチ市場:流通チャネル別

  • オフライン
  • オンライン

第9章 自己創傷パッチ市場:エンドユーザー別

  • 外来手術センター
  • ホームケア
  • 病院・クリニック

第10章 南北アメリカの自己創傷パッチ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の自己創傷パッチ市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの自己創傷パッチ市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • 3M Company
  • Avita Medical
  • Axio Biosolutions Pvt. Ltd. by Advamedica Inc.
  • Healiva SA
  • Integra LifeSciences
  • Medline Industries, Inc.
  • MIMEDX Group, Inc.
  • Molnlycke AB
  • PolarityTE, Inc. by Grander
  • PRP Concepts, Inc.
  • Reapplix A/S
  • RedDress Medical Ltd.
  • Smith+Nephew PLC
  • SweetBio Inc.
図表

LIST OF FIGURES

  • FIGURE 1. AUTOLOGOUS WOUND PATCHES MARKET RESEARCH PROCESS
  • FIGURE 2. AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. AUTOLOGOUS WOUND PATCHES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. AUTOLOGOUS WOUND PATCHES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AUTOLOGOUS WOUND PATCHES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AUTOLOGOUS WOUND PATCHES MARKET DYNAMICS
  • TABLE 7. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY PLATELET RICH FIBRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY PLATELET RICH PLASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY BURNS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY SURGICAL & TRAUMATIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY VENOUS LEG ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH KOREA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. TAIWAN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. THAILAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. VIETNAM AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 151. DENMARK AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EGYPT AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. FINLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. FRANCE AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. GERMANY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. ISRAEL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. ITALY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. NETHERLANDS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. NIGERIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. NORWAY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. POLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. QATAR AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. RUSSIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. SAUDI ARABIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. SPAIN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. SWEDEN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. SWITZERLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. TURKEY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY WOUND, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM AUTOLOGOUS WOUND PATCHES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. AUTOLOGOUS WOUND PATCHES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 278. AUTOLOGOUS WOUND PATCHES MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-742BD517B3A2

The Autologous Wound Patches Market was valued at USD 78.24 million in 2023, expected to reach USD 88.40 million in 2024, and is projected to grow at a CAGR of 13.39%, to USD 188.58 million by 2030.

Autologous wound patches, a vital innovation in the healthcare industry, involve using a patient's own cells to create therapeutic patches that promote wound healing. The necessity of these patches stems from their potential to significantly reduce the risk of infection and rejection, as they are autologous in nature, ensuring greater biocompatibility. These patches find extensive applications in chronic wound management, surgical wounds, and ulcer treatments, alongside promising use in diabetic wound healing due to their natural compatibility and effectiveness in tissue regeneration. End-use scopes span hospitals, outpatient centers, and specialized clinics, pushing for widespread healthcare adoption.

KEY MARKET STATISTICS
Base Year [2023] USD 78.24 million
Estimated Year [2024] USD 88.40 million
Forecast Year [2030] USD 188.58 million
CAGR (%) 13.39%

The market for autologous wound patches is primarily driven by the increasing prevalence of chronic wounds, rising awareness of advanced wound care, and the growing elderly population who are more prone to wound complications. Furthermore, technological advancements in tissue engineering and regenerative medicine play a crucial role in market expansion. Potential opportunities lie in the integration of AI and machine learning to personalize treatment plans and improve the effectiveness of patches. Recommendations for market players include investing in R&D to enhance product efficacy and establishing strategic partnerships with healthcare providers to bolster distribution networks.

Conversely, limitations such as high costs, a complex regulatory landscape, and limited awareness, particularly in developing regions, pose challenges to market growth. Furthermore, the technical challenges in harvesting and culturing autologous cells add to the complexity and potential cost burden, limiting accessibility. Innovation in this field is rooted in the enhancement of biofabrication techniques, and personalized medicine approaches could revolutionize the market by tailoring treatments to individual patient needs. The nature of the market is dynamic and competitive, with a high potential for growth as technological advancements and regulatory approvals align effectively with increasing healthcare demands. Focusing on scalability and cost reduction can further accelerate market penetration and acceptance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Autologous Wound Patches Market

The Autologous Wound Patches Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of acute and chronic wounds globally
    • Increasing number of roads and traumatic accidents
    • Favorable reimbursement policies for autologous wound patches
  • Market Restraints
    • High cost associated with autologous wound patches
  • Market Opportunities
    • Introduction of smart patches for wound healing
    • Ongoing research activities for the development of autologous wound patches
  • Market Challenges
    • Availability of alternatives for wound treatment

Porter's Five Forces: A Strategic Tool for Navigating the Autologous Wound Patches Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Autologous Wound Patches Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Autologous Wound Patches Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Autologous Wound Patches Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Autologous Wound Patches Market

A detailed market share analysis in the Autologous Wound Patches Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Autologous Wound Patches Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Autologous Wound Patches Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Autologous Wound Patches Market

A strategic analysis of the Autologous Wound Patches Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Autologous Wound Patches Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Avita Medical, Axio Biosolutions Pvt. Ltd. by Advamedica Inc., Healiva SA, Integra LifeSciences, Medline Industries, Inc., MIMEDX Group, Inc., Molnlycke AB, PolarityTE, Inc. by Grander, PRP Concepts, Inc., Reapplix A/S, RedDress Medical Ltd., Smith+Nephew PLC, and SweetBio Inc..

Market Segmentation & Coverage

This research report categorizes the Autologous Wound Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Platelet Rich Fibrin and Platelet Rich Plasma.
  • Based on Wound, market is studied across Acute Wounds and Chronic Wounds. The Acute Wounds is further studied across Burns and Surgical & Traumatic Wounds. The Chronic Wounds is further studied across Diabetic Foot Ulcers, Pressure Ulcers, and Venous Leg Ulcers.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Homecare, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of acute and chronic wounds globally
      • 5.1.1.2. Increasing number of roads and traumatic accidents
      • 5.1.1.3. Favorable reimbursement policies for autologous wound patches
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with autologous wound patches
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of smart patches for wound healing
      • 5.1.3.2. Ongoing research activities for the development of autologous wound patches
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternatives for wound treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Autologous Wound Patches Market, by Type

  • 6.1. Introduction
  • 6.2. Platelet Rich Fibrin
  • 6.3. Platelet Rich Plasma

7. Autologous Wound Patches Market, by Wound

  • 7.1. Introduction
  • 7.2. Acute Wounds
    • 7.2.1. Burns
    • 7.2.2. Surgical & Traumatic Wounds
  • 7.3. Chronic Wounds
    • 7.3.1. Diabetic Foot Ulcers
    • 7.3.2. Pressure Ulcers
    • 7.3.3. Venous Leg Ulcers

8. Autologous Wound Patches Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
  • 8.3. Online

9. Autologous Wound Patches Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Homecare
  • 9.4. Hospitals & Clinics

10. Americas Autologous Wound Patches Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Autologous Wound Patches Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Autologous Wound Patches Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Avita Medical
  • 3. Axio Biosolutions Pvt. Ltd. by Advamedica Inc.
  • 4. Healiva SA
  • 5. Integra LifeSciences
  • 6. Medline Industries, Inc.
  • 7. MIMEDX Group, Inc.
  • 8. Molnlycke AB
  • 9. PolarityTE, Inc. by Grander
  • 10. PRP Concepts, Inc.
  • 11. Reapplix A/S
  • 12. RedDress Medical Ltd.
  • 13. Smith+Nephew PLC
  • 14. SweetBio Inc.